Gene · 4100
MAGEA1: MAGE family member A1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MAGEA1: MAGE family member A1. Genes, record 4100. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4100
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P43355 | Melanoma-associated antigen 1 | 309 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents161
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4641201 A2 | 2025-10-29 | 7278 | P43355 | Espacenet |
| JP 2025160297 A | 2025-10-22 | 120 | P43355 | Espacenet |
| JP 2025533851 A | 2025-10-09 | 15 | P43355 | Espacenet |
| WO 2025146286 A1 | 2025-07-10 | 31 | P43355 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7278 | P43355 | Espacenet |
| JP 2025084910 A | 2025-06-03 | 21 | P43355 | Espacenet |
| JP 2025516264 A | 2025-05-27 | 40 | P43355 | Espacenet |
| US 12280021 B2 | 2025-04-22 | 117 | P43355 | Espacenet |
| JP 2025062611 A | 2025-04-14 | 90 | P43355 | Espacenet |
| US 12269793 B2 | 2025-04-08 | 117 | P43355 | Espacenet |
1 to 10 of 161
See all 161 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants735
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MAGEA1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 13 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 12 | 2025 |
| P30CA044579 | University of Virginia Cancer Center Support Grant | 11 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| ZIABC010985 | Gene therapy of cancer | 7 | 2025 |
| ZIABC010984 | Adoptive Cell Transfer Immunotherapy of Cancer | 5 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| T32CA163177 | Postdoctoral Training Grant for MDs in Surgical Oncology Research | 4 | 2025 |
| ZIAAI000860 | Deciphering CTCF code in human host and viral epigenomes | 4 | 2025 |
1 to 10 of 735Source NIH's project files
See all 735 nih grantsPapers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative diagnostic value of a blood-based three-gene DNA methylation assay and a seven-autoantibody panel for differentiating pulmonary nodules. | J Liq Biopsy | 2026 | 42825038 | PubTator, text mining | PubMed |
| Targeting the β2-adrenergic receptor suppresses melanoma progression by disrupting the PKA-SOX10-MAGEA1 oncogenic axis. | Biochem Pharmacol | 2026 | 42604673 | PubTator, text mining | PubMed |
| The Construction and Preclinical Evaluation of Antitumor Activity of a Novel MIgG-OXA ADC in Lung Adenocarcinoma. | Oncol Res | 2026 | 42500564 | PubTator, text mining | PubMed |
| Hypomethylation of FAM83A in lung adenocarcinoma mirrors an epigenetic signature of airway cell differentiation states. | Discov Oncol | 2026 | 42251611 | PubTator, text mining | PubMed |
| Molecular subtyping and prognostic model construction based on endosome-related genes in colorectal cancer. | J Gastrointest Oncol | 2026 | 42169884 | PubTator, text mining | PubMed |
| DNA methylation as a predictor of pituitary neuroendocrine tumour behaviour: A systematic review. | J Neuroendocrinol | 2026 | 41866138 | PubTator, text mining | PubMed |
| Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering. | Science | 2026 | 41855322 | PubTator, text mining | PubMed |
| The early diagnostic value of lung cancer autoantibodies and tumor markers in lung cancer. | Clin Transl Oncol | 2026 | 41824177 | PubTator, text mining | PubMed |
| Cross-Species Upregulation of MAGED2 in Liver Cancer Suggests a Role in Obesity-Driven Tumor Progression. | Curr Issues Mol Biol | 2026 | 41751403 | PubTator, text mining | PubMed |
| Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives. | Vaccines (Basel) | 2026 | 41746109 | PubTator, text mining | PubMed |
1 to 10 of 1,534
See all 1,534 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4100
GET https://conductscience.org/api/genes/v1/4100/patents?page=2